<DOC>
	<DOCNO>NCT01900301</DOCNO>
	<brief_summary>Fear , whether occurs human suffer anxiety disorder experimental model rodent , reduce expose frightened organism fearful stimulus absence negative consequence ( i.e. , extinction , exposure therapy ) . However , fear often renew fear stimulus encounter context different exposure context . In rat , investigator find interfere animal 's ability process context extinction administer anticholinergic drug prevent fear renewal . This proposal determine beneficial effect drug translate exposure therapy socially anxious human . To end , 100 individual Social Phobia fear public speaking undergo repeat session exposure public speaking , within virtual reality context . Participants randomize either drug placebo , .2mg/.01 mL Scopolamine , .3mg/.01 mL Scopolamine .4mg/.01 mL Scopolamine , administer via nasal drop , prior session exposure therapy . One month completion exposure therapy , context renewal test compare physiological subjective response public speak virtual context use exposure therapy versus context different one use exposure therapy . The goal identify dose Scopolamine associate great reduction context renewal . In addition , secondary analysis attempt identify individual benefit Scopolamine-augmentation exposure therapy .</brief_summary>
	<brief_title>Generalization Extinction Learning</brief_title>
	<detailed_description />
	<mesh_term>Anxiety Disorders</mesh_term>
	<mesh_term>Phobic Disorders</mesh_term>
	<mesh_term>Scopolamine Hydrobromide</mesh_term>
	<mesh_term>Butylscopolammonium Bromide</mesh_term>
	<criteria>1. age 18 55 , 2. fluent English , 3. within normal body weight ( BMI=18.5 24.9 ) 4. meet DSMIV diagnostic criterion Social Phobia report fear public speaking . 1. participant report diagnose medical neurological disorder 2. prescription counter medication interact Scopolamine , anticholinergic medication ( e.g . belladonna alkaloid , antihistamine , meclizine , tricyclic antidepressant , muscle relaxant ) , cold medicine , cough suppressant . Other drug reason exclusion include : antimuscarinics , nifedipine , parasympathomimetics , amantadine , amoxapine , antacid , antidiarrheal , anxiolytic , hypnotic , atomexetine , bupropion , cisapride , clozapine , cyclobenzaprine , digoxin , disopyramide , dronabinol ( THC ) , ethanol , maprotilline , memantine , metoclopramide , nabilone , olanzapine , opiate agonist , orphenadrine , phenothiazine , potassium salt , quinidine , sedate H1blockers , topiramate , tricyclic antidepressant , erthyromycin , ketoconazole , tegaserod . 3. counter drug substance may sedative effect ( e.g . herbal sedative : ashwagandha , Duboisia hopwoodii , Prostanthera striatiflora , kava , mandrake , valerian , cannabis , passiflora incarnate ; Antihistamines : Diphenhydramine , Dimenhydrinate , Doxylamine , Promethazine ; Alcohol ; Dextromethorphan ) 4. individual urinary problem ( e.g. , BPH ) 5. pregnant nursing female ( effect Scop fetuses know ) 6. suicidality 7. delusion hallucination 8. history substance dependence last five year substance abuse within past 6 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>exposure</keyword>
	<keyword>scopolamine</keyword>
	<keyword>extinction learning</keyword>
	<keyword>social anxiety</keyword>
</DOC>